IPG positioned to further accelerate expansion of innovative surgical cost management platform
BALTIMORE, Maryland (April 20, 2021) – Camden Partners today announced the sale of portfolio company, Implantable Provider Group, Inc. (“IPG” or the “Company”), a leading provider of surgical cost management solutions to TPG Growth, the middle-market and growth equity platform of alternative asset firm TPG. Camden Partners Managing Partner Todd Sherman, who focuses on growth equity investments in software, fin tech and healthcare services companies, represented Camden on IPG’s Board of Directors.
The Company has experienced tremendous growth since Camden’s original investment in August 2013. Following the addition of Vince Coppola as President and CEO in 2016, IPG’s growth accelerated as a result of improving inefficient processes and communication throughout the organization, strengthening the core leadership team, and implementing a health plan focused model. The ability to execute on their growth initiatives enabled IPG to grow the Company’s existing business and expand into additional markets.
Partnering with health plans, device manufacturers, and surgical facilities nationwide, IPG offers high-quality, cost-effective surgical solutions, as well as increased transparency and alignment to stakeholders across the healthcare market. The IPG platform combines in-depth analytics and expertise in device cost management, to enable cost effective site of care optimization and provide detailed surgical cost analytics for the delivery of value-based care.
“We’re proud of the significant organic growth IPG has achieved in establishing an innovative platform, with proven value proposition,” said Todd Sherman. “It’s been a pleasure to partner with Vince Coppola and the entire IPG team as they’ve successfully transformed into a company with stronger strategic client relationships, aligned with industry trends, and focused on transparency and data.”
“This is an exciting time for IPG and our partnership with TPG is a testament to our dedicated employees, the strength of our mission, and the surgical management platform we have built,” said Vince Coppola. “IPG’s business has grown rapidly, driven by our strong value proposition and commitment to increasing patient access to cost-effective surgical care. Coppola added, “We would also like to thank previous investors Sequoia Capital and Camden Partners for their support as IPG has delivered on its value proposition and successfully executed its growth strategy.”
IPG is the leading provider of Surgical Cost Management solutions, working with health plans, providers, surgical facilities, device manufacturers and patients across the country to improve quality and reduce costs for surgical procedures through optimization of the most effective site of care and device selection, resulting in more affordable high-quality care to consumers. For more information about IPG, call us at 866.753.0046, or visit us on the web at www.ipg.com.
About Camden Partners
Founded in 1995, Camden Partners is a Baltimore-based lower-middle market growth equity firm. For over 25 years Camden has consistently focused on investing in growth-stage companies with enterprise values ranging from $10 million - $150 million. Leveraging their domain expertise in technology & enterprise SaaS, business services, and education, Camden partners with their portfolio companies to grow revenue and increase cash flow by setting organizational strategy and providing the growth capital to expand operations. Camden's target equity checks range between $5 million and $15 million, allowing them to be a preferred partner of choice for owner-operators of businesses who maybe dilution sensitive.